AHI System vs EchoNext

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AHI System

by Fifth Eye

EchoNext

by Pathway Labs

AI Verdict

Both AHI System and EchoNext are FDA-cleared AI tools that leverage ECG data for cardiac insights, making them adjacent competitors. AHI System focuses on real-time predictive analytics for hemodynamic instability, providing early warnings for patient deterioration. EchoNext, on the other hand, analyzes standard ECGs to detect hidden structural heart diseases like heart failure and valve disease, acting as a screening tool for earlier diagnosis.

Choose AHI System if…

Choose AHI System if your hospital needs real-time, continuous predictive analytics to detect patient deterioration hours before vital signs indicate a problem, particularly for hemodynamic instability. This tool is ideal for critical care, emergency medicine, and hospital medicine settings to proactively manage patient risk, reduce nursing workload, and optimize resource allocation.

View AHI System →

Choose EchoNext if…

Choose EchoNext if your practice or hospital aims to screen a broad patient population for hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension, using standard 12-lead ECGs. This tool is best suited for early detection and identifying patients who require further diagnostic imaging like an echocardiogram, even when a cardiologist might miss it.

View EchoNext →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AHI System	EchoNext
Pricing	Contact for pricing	Starts at $600/month
Deployment	Software-only device, integrates with existing hospital IT infrastructure and patient monitoring platforms.	Available through the OpenEvidence clinical decision support platform.
BAA Available	Unknown	Yes AI-estimated
FDA Status	Yes AI-estimated	Yes AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Both tools are software-only and integrate with existing hospital infrastructure. AHI System integrates with patient monitoring platforms, while EchoNext is available through the OpenEvidence platform. Without further information on the user interface or specific workflows, it's difficult to definitively declare a winner in usability.

Clinical Value

AHI System

AHI System provides real-time predictive analytics for hemodynamic instability, detecting patient deterioration hours before vital signs change, which can significantly impact patient outcomes in critical care settings. EchoNext detects hidden structural heart disease from ECGs, which is valuable for diagnosis, but AHI's real-time, predictive nature for acute events offers a more immediate and potentially life-saving clinical impact.

Pricing & Value

EchoNext

EchoNext offers transparent tiered pricing starting at $600/month, with details on implementation fees and discounts. AHI System's pricing is 'contact for pricing,' which makes it less transparent and harder to assess its value proposition without direct engagement.

Enterprise Readiness

Tie

Both tools are FDA-cleared, HIPAA compliant, and offer Business Associate Agreements (BAAs), indicating readiness for enterprise deployment in healthcare settings. AHI System integrates with existing hospital IT and monitoring platforms, while EchoNext is available through a clinical decision support platform. Both appear to meet the foundational requirements for enterprise use.

Innovation

AHI System

AHI System's ability to provide real-time predictive analytics for hemodynamic instability hours before vital sign changes, utilizing continuous ECG signals, represents a significant innovation in proactive patient management and early intervention. While EchoNext's AI-powered ECG analysis for hidden structural heart disease is innovative, AHI's predictive capability for acute deterioration stands out.

Support & Docs

Tie

Neither the provided structured facts nor readily available web searches offer specific details on the level of support or documentation provided by either Fifth Eye for AHI System or Pathway Labs for EchoNext. Therefore, it is not possible to distinguish between the two on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AHI System	EchoNext
Name	AHI System	EchoNext
Company	Fifth Eye	Pathway Labs
Primary Function	Real-time predictive analytics for hemodynamic instability, detecting patient deterioration hours before vital signs.	Analyzes standard ECGs to detect hidden structural heart disease (heart failure, valve disease, pulmonary hypertension).
Key Input Data	Continuous Lead II ECG signals	Standard 12-lead ECGs
Specialties	Critical Care, Emergency Medicine, Hospital Medicine	Cardiology, Family Medicine, Hospital Medicine, Internal Medicine
Target User/Setting	Not specified	Broad access, from major hospitals to community practices.

Videos

Demos, reviews, and walkthroughs featuring AHI System and EchoNext.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and EHR systems?

The AHI System integrates with existing hospital IT infrastructure and patient monitoring platforms like Sickbay and VitalConnect, embedding its capabilities directly within these platforms to simplify deployment and use. EchoNext is available through the OpenEvidence clinical decision support platform, which is used by a significant number of U.S. clinicians, allowing its screening outputs to be directly integrated into common clinical workflows without requiring a separate system.

What are the key differences in the accuracy and sensitivity of these tools?

The AHI System demonstrated 96% sensitivity and 85% specificity in detecting hemodynamic instability in an FDA-reviewed study. EchoNext, in a 2025 study, correctly identified 77% of structural heart problems from ECGs, outperforming cardiologists who had 64% accuracy with the same ECGs.

Which clinical specialties are these tools best suited for, and what specific clinical problems do they address?

The AHI System is designed for critical care, emergency medicine, and hospital medicine, providing real-time predictive analytics for hemodynamic instability to detect patient deterioration hours before vital signs change. EchoNext is suited for cardiology, family medicine, hospital medicine, and internal medicine, focusing on detecting hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension, from standard ECGs.

What is the expected learning curve for physicians to effectively use each tool?

The AHI System aims to reduce nursing burden by providing reliable early warnings, suggesting an intuitive interface when integrated with existing monitoring platforms. EchoNext is integrated into the OpenEvidence platform, which is already used by many physicians, potentially reducing the learning curve as it leverages a familiar interface for delivering its insights.

What audit-trail features are available to support clinical decision-making and review?

While specific audit-trail features are not detailed for EchoNext, the AHI System's FDA documentation mentions that clinicians should consider AHI outputs in the context of other clinical information to determine appropriate action, implying a need for comprehensive record-keeping. Both tools, as clinical decision support software, would generally be expected to maintain records of their analyses and alerts to support clinical review and accountability.